Kempner Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.64M Sell
28,548
-2,853
-9% -$271K 2.49% 17
2025
Q3
$3.09M Sell
31,401
-27,095
-46% -$2.68M 2.57% 15
2025
Q2
$5.33M Buy
58,496
+18,896
+48% +$1.83M 2.86% 14
2025
Q1
$4.48M Hold
39,600
2.52% 21
2024
Q4
$4.18M Buy
39,600
+13,349
+51% +$1.43M 2.3% 23
2024
Q3
$2.83M Buy
+26,251
New +$2.86M 1.45% 32
2019
Q1
Sell
-14,215
Closed -$1.43M 50
2018
Q4
$1.43M Buy
14,215
+3,026
+27% +$340K 0.98% 34
2018
Q3
$1.43M Sell
11,189
-2
-0% -$238 0.92% 33
2018
Q2
$1.21M Hold
11,191
0.8% 37
2018
Q1
$1.19M Buy
11,191
+11
+0.1% +$1.28K 0.81% 34
2017
Q4
$1.31M Sell
11,180
-111
-1% -$12.6K 0.82% 34
2017
Q3
$1.28M Sell
11,291
-7,050
-38% -$814K 0.85% 33
2017
Q2
$2.29M Buy
18,341
+321
+2% +$38.1K 1.5% 23
2017
Q1
$2.14M Buy
18,020
+2,379
+15% +$270K 1.42% 25
2016
Q4
$1.57M Buy
+15,641
New +$1.68M 1.14% 31

Other funds holding ZBH

Kempner Capital Management's ZBH Position: Q4 2025 in Review

Kempner Capital Management reduced its Zimmer Biomet (ZBH) stake by 9.1% in Q4 2025, selling an estimated $271K and leaving 28,548 shares worth $2.64M. The position accounts for 2.49% of the portfolio, ranked #17.

Kempner Capital Management first reported a position in ZBH in Q4 2016 and has held it in 15 quarters since. The position peaked at $5.33M in Q2 2025. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Kempner Capital Management held 28,548 shares of Zimmer Biomet worth $2.64M as of Q4 2025.
  • Kempner Capital Management sold 2,853 Zimmer Biomet shares in Q4 2025, an estimated $271K.
  • Zimmer Biomet made up 2.49% of Kempner Capital Management's portfolio in Q4 2025, its #17 holding.
  • Kempner Capital Management first reported a position in Zimmer Biomet in Q4 2016 and has held it in 15 quarters since.
  • Kempner Capital Management's Zimmer Biomet position peaked at $5.33M in Q2 2025.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Kempner Capital Management's 13F filing for Q4 2025, filed 12 Jan 2026.